Cargando…
Large-scale labeling and assessment of sex bias in publicly available expression data
BACKGROUND: Women are at more than 1.5-fold higher risk for clinically relevant adverse drug events. While this higher prevalence is partially due to gender-related effects, biological sex differences likely also impact drug response. Publicly available gene expression databases provide a unique opp...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011224/ https://www.ncbi.nlm.nih.gov/pubmed/33784977 http://dx.doi.org/10.1186/s12859-021-04070-2 |